+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ZYDUSWELL

Zydus Wellness Share Price

₹470.05 -4.05 (-0.85%)
27.89% Gain from 52W Low

27 Oct, 2026 1:49 PM (IST)

Zydus Wellness live price: ₹470.05. It opened at ₹470 vs previous close ₹474; intraday high/low: ₹482/₹465. The 50 & 200 DMA stand at ₹514.30/₹498.00.

Zydus Wellness Performance

  • Today's Low
  • ₹465
  • Today's High
  • ₹482
  • 52 Week Low
  • ₹368
  • 52 Week High
  • ₹612
  • Open Price₹470
  • Previous Close₹474
  • Volume73,072
  • 50 DMA₹514.30
  • 100 DMA₹515.60
  • 200 DMA₹498.00

Zydus Wellness Chart

Investment Returns

  • Over 1 Month -9.71%
  • Over 3 Month -16.52%
  • Over 6 Month -4.24%
  • Over 1 Year -3.06%

Smart Investing Starts Here Start SIP with Zydus Wellness for Steady Growth!

Invest Now

Zydus Wellness Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 79.5
  • PEG Ratio
  • -1.9
  • Market Cap Cr
  • 14,955
  • P/B Ratio
  • 2.5
  • Average True Range
  • 17.9
  • EPS
  • 5.9
  • Dividend Yield
  • 0.3
  • MACD Signal
  • -11.8
  • RSI
  • 38.54
  • MFI
  • 54.1

Latest Stock News Updates

Zydus Wellness Ltd-$ - 531335 - Clarification On Recent News Item Dated October 22, 2026

Clarification on recent news item dated October 22, 2026

Zydus Wellness Ltd-$ - 531335 - Clarification sought from Zydus Wellness Ltd

The Exchange has sought Clarification from Zydus Wellness Ltd with reference to the media report appearing on https://www.firstpost.com dated October 22, 2026 titled "FSSAI issues notices to Nestle India, Zydus Wellness over alleged misleading product claims" (Link: https://www.firstpost.com/business/fssai-issues-notices-to-nestle-india-zydus-wellness-over-alleged-misleading-product-claims-14054416.html).The Company is requested to submit its clarification to the Exchange in terms of the provisions of Regulation 30 of the SEBI (LODR) Regulations, 2015.

Zydus Lifesciences gets USFDA nod for menopause treatment drug

The final approval granted by the US Food and Drug Administration (USFDA) is for Estradiol and Levonorgestrel Transdermal System (0.045 mg/0.015 mg per day)

Zydus Wellness Financials

Zydus Wellness Technicals

EMA & SMA

Current Price
₹470.05
-4.05 (-0.85%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹499.70
  • 50 Day
  • ₹514.30
  • 100 Day
  • ₹515.60
  • 200 Day
  • ₹498.00

Resistance and Support

472.52 Pivot Speed
  • R3 504.20
  • R2 490.60
  • R1 482.30
  • S1 460.40
  • S2 446.80
  • S3 438.50

Zydus Wellness Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-11-03 Quarterly Results
2026-08-04 Quarterly Results
2026-05-18 Audited Results & Final Dividend
2026-02-03 Quarterly Results
2025-11-05 Quarterly Results
Date Purpose Remarks
2026-07-17 FINAL Rs.1.20 per share(60%)Final Dividend
2025-07-11 FINAL Rs.6.00 per share(60%)Final Dividend
2024-07-19 FINAL Rs.5.00 per share(50%)Final Dividend
2023-07-21 FINAL Rs.5.00 per share(50%)Final Dividend
2022-07-15 FINAL Rs.5.00 per share(50%)Final Dividend
View Zydus Wellness Dividend History Arrow
Date Purpose Remarks
2025-09-18 Split Stock split from Rs. 10/- to Rs. 2/-.

Zydus Wellness Shareholding Pattern

69.64%
18.72%
7.42%
3.57%
0.67%

About Zydus Wellness

Zydus Wellness is engaged in business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. View More
  • NSE Symbol
  • ZYDUSWELL
  • BSE Symbol
  • 531335
  • ISIN
  • INE768C01028

Similar Stocks to Zydus Wellness

Zydus Wellness FAQs

Zydus Wellness share price is ₹470 As on 27 October, 2026 | 13:37

The Market Cap of Zydus Wellness is ₹14955.1 Cr As on 27 October, 2026 | 13:37

The P/E ratio of Zydus Wellness is 79.5 As on 27 October, 2026 | 13:37

The PB ratio of Zydus Wellness is 2.5 As on 27 October, 2026 | 13:37

The 52 week High & Low of Zydus Wellness is ₹611.8/₹367.6 respectively As on 27 October, 2026 | 13:37

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23